NCT00889447|CompletedDMC
Loading search results
Sponsor study identifier
Secondary identifiers
NIH
observational
670
1 country
1
Study Start
January 2008
Actual (reported)Primary Completion
May 2017
Actual (reported)Study Completion
May 2017
Actual (reported)This research is being done to study mechanisms of progression of COPD and to develop treatments for it. The investigators are doing the present study to identify people age 40 and older with mild to moderate COPD who will qualify for such studies to include in a database. The study will include establishing a screening evaluation or characterization of the following two studies:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 2017
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2008
Actual (reported)April 27, 2009
Actual (reported)April 29, 2009
Actual (reported)May 2017
Actual (reported)May 2017
Actual (reported)Establish a screening evaluation or characterization
We are doing the present study to identify people to include in a database who are age 40 and older with mild to moderate COPD and who will qualify for studies of COPD. The study will include establishing a screening evaluation or characterization for the following three studies. * Emphysema Progression in COPD- Losartan's Effects on Airway Parameters - NA\_00009980 * Sleep-Related Physiology and Inflammation in Chronic Obstructive Pulmonary Disease - NA\_00001771 * Genetic Epidemiology of Chronic Obstructive Pulmonary Disease - NA\_00011524
Determined during screening clinical visit
Both Male and Female 40 years and older
Johns Hopkins Asthma and Allergy Center
Baltimore, Maryland, 21224, United States
blood
Gregory Diette, MD,MHS
Johns Hopkins University
670 participants (actual enrollment reported by the registry).
First Submitted
April 27, 2009
First Posted
April 29, 2009
Study Start
January 2008
Actual (reported)Lovastatin as a Potential Modulator of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)
Contact the study team to confirm eligibility.
Primary Completion
May 2017
Actual (reported)Study Completion
May 2017
Actual (reported)Last Updated
March 12, 2018
Record last verified: 2018-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: